The five-year reauthorization of spending for US Department of Agriculture programs Congress passed in 2018 ignited the Food and Drug Administration’s consideration of a regulatory pathway for using hemp in dietary supplements.
It could take the next farm bill, which is on lawmakers’ 2023 to-do list, to extinguish an inferno of disagreement between the FDA and stakeholders in regulated industries over lawful use of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?